This inventor holds 1 USPTO granted patent. Top assignee: Hypoxi Co., Ltd.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Innovations by Mee-Jung Han in Cell Culture Technology.
Introduction
Mee-Jung Han is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of cell culture technology, particularly in enhancing the survival rates of cells under challenging conditions. His innovative approach has the potential to impact various applications in biotechnology and medicine.
Latest Patents
Mee-Jung Han holds a patent for a method aimed at increasing the survival rate of cells in animal cell culture under hypoxic conditions. The patent describes a technique that involves adding antibiotics to the culture media. Specifically, the method includes culturing animal cells in media containing antibacterial agents such as quinolones, quinones, aminoglycosides, or chloramphenicol at concentrations ranging from 0.1 to 1000 µg/ml. This invention is particularly useful for high-density animal cell cultures, which are essential for producing recombinant proteins or cultured cells.
Career Highlights
Mee-Jung Han is associated with Hypoxi Co., Ltd., where he applies his expertise in cell culture technology. His work focuses on developing methods that enhance cell viability and productivity in various biotechnological applications. His innovative contributions have positioned him as a key figure in his field.
Collaborations
Mee-Jung Han has collaborated with notable colleagues, including Jongwon Lee and Kyu-Won Kim. These collaborations have fostered a productive environment for research and development in cell culture methodologies.
Conclusion
Mee-Jung Han's innovative methods in cell culture technology demonstrate his commitment to advancing biotechnological applications. His patent for increasing cell survival rates under hypoxic conditions is a testament to his ingenuity and dedication to improving cell culture practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile